Regulation of alternative splicing by snoRNAs
- PMID: 17381313
- DOI: 10.1101/sqb.2006.71.024
Regulation of alternative splicing by snoRNAs
Abstract
The SNURF-SNRPN locus located on chromosome 15 is maternally imprinted and generates a large transcript containing at least 148 exons. Loss of the paternal allele causes Prader-Willi syndrome (PWS). The 3' end of the transcript harbors several evolutionarily conserved C/D box small nucleolar RNAs (snoRNAs) that are tissue-specifically expressed. With the exception of 47 copies of HBII-52 snoRNAs, none of the snoRNAs exhibit complementarity to known RNAs. Due to an 18-nucleotide sequence complementarity, HBII-52 can bind to the alternatively spliced exon Vb of the serotonin receptor 2C pre-mRNA, where it masks a splicing silencer, which results in alternative exon usage. This silencer can also be destroyed by RNA editing, which changes the amino acid sequence and appears to be independent of HBII-52. Lack of HBII-52 expression in individuals with PWS causes most likely a lack of the high-efficacy serotonin receptor, which could contribute to the disease. It is therefore possible that snoRNAs could act as versatile modulators of gene expression by modulating alternative splicing.
Similar articles
-
The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C.Science. 2006 Jan 13;311(5758):230-2. doi: 10.1126/science.1118265. Epub 2005 Dec 15. Science. 2006. PMID: 16357227
-
The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A.Hum Mol Genet. 2001 Nov 1;10(23):2687-700. doi: 10.1093/hmg/10.23.2687. Hum Mol Genet. 2001. PMID: 11726556
-
Molecular breakpoint cloning and gene expression studies of a novel translocation t(4;15)(q27;q11.2) associated with Prader-Willi syndrome.BMC Med Genet. 2005 May 6;6:18. doi: 10.1186/1471-2350-6-18. BMC Med Genet. 2005. PMID: 15877813 Free PMC article.
-
Small mosaic deletion encompassing the snoRNAs and SNURF-SNRPN results in an atypical Prader-Willi syndrome phenotype.Am J Med Genet A. 2014 Feb;164A(2):425-31. doi: 10.1002/ajmg.a.36307. Epub 2013 Dec 5. Am J Med Genet A. 2014. PMID: 24311433 Review.
-
Brain-specific small nucleolar RNAs.J Mol Neurosci. 2006;28(2):103-9. doi: 10.1385/JMN:28:2:103. J Mol Neurosci. 2006. PMID: 16679551 Review.
Cited by
-
Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease.Trends Mol Med. 2021 Jul;27(7):643-659. doi: 10.1016/j.molmed.2021.04.005. Epub 2021 May 13. Trends Mol Med. 2021. PMID: 33994320 Free PMC article. Review.
-
Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration.Front Genet. 2013 Jan 22;3:326. doi: 10.3389/fgene.2012.00326. eCollection 2012. Front Genet. 2013. PMID: 23346095 Free PMC article.
-
Targeting RNA in mammalian systems with small molecules.Wiley Interdiscip Rev RNA. 2018 Jul;9(4):e1477. doi: 10.1002/wrna.1477. Epub 2018 May 3. Wiley Interdiscip Rev RNA. 2018. PMID: 29726113 Free PMC article. Review.
-
Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability.Mol Psychiatry. 2012 Nov;17(11):1103-15. doi: 10.1038/mp.2011.163. Epub 2011 Dec 20. Mol Psychiatry. 2012. PMID: 22182939 Free PMC article.
-
Small Nucleolar RNAs: Biological Functions and Diseases.MedComm (2020). 2025 Jun 27;6(7):e70257. doi: 10.1002/mco2.70257. eCollection 2025 Jul. MedComm (2020). 2025. PMID: 40584410 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources